Skip to main content

Drug-Induced Bradycardia:When Is a Pacemaker Warranted?

  • Conference paper
Cardiac Arrhythmias 2003
  • 62 Accesses

Abstract

Pacing and drug therapy may interact in cardiac patients in several ways, and one of them is when drug therapy induces bradycardia necessitating antibradycardia pacing. In this paper, several aspects of drug-induced bradycardia (DIB) will be discussed: definition, epidemiology, physiology, pathogenesis, drugs leading to bradycardia, clinical settings when DIB can require pacing, and management of DIB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gregoratos G, Abrams J, Epstein AE et al (2002) ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 106:2145–61

    Article  PubMed  Google Scholar 

  2. Israel CW, Ehrlich JR., Barold SS et al (2002) Treatment of tachyarrhythmias with pacing and antiarrhythmic drugs. In: Israel CW, Barold SS (eds) Advances in the treatment of atrial tachyarrhythmias: pacing, cardioversion, and defibrillation. Futura, Armonk, NY, pp 305–323

    Google Scholar 

  3. Essebag V, Hadjis T, Platt RW et al (2003) Amiodarone and the risk of bradyarrhyth-mia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol 15:249–254

    Article  Google Scholar 

  4. Reynolds MR, Hadjis T, Schwartzman DS et al (2003) Age and amiodarone use are important determinants of the need for permanent pacing among new onset AF patients (abstract). Pacing Clin Electrophysiol 26:1016, A350

    Google Scholar 

  5. Friedman PL, Stevenson WG (1998) Proarrhythmia. Am J Cardiol 82:50N–58N

    Article  PubMed  CAS  Google Scholar 

  6. Ovsyshcher I, Zimlichman R, Bondy C et al (1993) Measurement of cardiac output by impedance cardiography in pacemaker patients at rest: effects of various AV delay. J Am Coll Cardiol 21:761–767

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Italia

About this paper

Cite this paper

Ovsyshcher, I.E., Gulko, N. (2004). Drug-Induced Bradycardia:When Is a Pacemaker Warranted?. In: Raviele, A. (eds) Cardiac Arrhythmias 2003. Springer, Milano. https://doi.org/10.1007/978-88-470-2137-2_91

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2137-2_91

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2177-8

  • Online ISBN: 978-88-470-2137-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics